netFormulary NHS
Birmingham, Sandwell, Solihull and environs APC Formulary
Maintained by Midlands and Lancashire Commissioning Support Unit
 Search
 Formulary Chapter 13: Skin - Full Chapter
Notes:

Please note: Silk garments are non-formulary.

 Details...
13.08.01  Expand sub section  Sunscreen preparations
Anthelios XL®
View adult BNF View SPC online View childrens BNF
Formulary
Green
  • Approved at December 2015 APC meeting following a drug application.

    Non-formulary if not for ACBS approved indication
 
Link  APC decision support tool
   
Sunsense® Ultra
(Lotion, SPF 50)
View adult BNF View SPC online View childrens BNF
Formulary
Green
Non-formulary if not for ACBS approved indication
 
   
13.08.01  Expand sub section  Photodamage
Diclofenac sodium 3% gel
View adult BNF View SPC online View childrens BNF
Formulary
Green
  • ££ 
  •    
    Cytotoxic Drug Fluorouracil (Efudix®)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
     
       
    fluorouracil 0.5%, salicylic acid 10% (Actikerall®)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    For hyperkeratotic lesions 
       
    Imiquimod 3.75%  (Zyclara®)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
  • £££
  • For field changes >25cm2 
  •    
    Imiquimod 5%  (Aldara®)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
     
       
    Ingenol mebutate (Picato®)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green

  • £ 
  • Link  APC decision support tool
    Link  FDA Drug Safety Communication: FDA warns of severe adverse events with application of Picato (ingenol mebutate) gel for skin condition; requires label changes
       
    Methyl-5-Aminolevulinate (Metvix®)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Red
     
       
     ....
     Non Formulary Items
    Borderline Substances  (Delph®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Borderline Substances  (SpectraBan®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Dundee reflective sun creams  (Dundee Block®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Sunscreen  (E45 Sun®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Sunscreen  (Roc®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Uvistat®

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
      
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to children's BNF
    click to search medicines.org.uk
    Link to SPCs
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Prescribing in children

    The APC notes that the informed use of unlicensed medicines or of licensed medicines for unlicensed applications (‘off-label’ use) is often necessary in paediatric practice.

    The APC advises GPs to consider specialist prescribing recommendations for Green and Amber medicines that are not subject to ESCAs or RICaDs in combination with the information provided in the BNFC which goes beyond that of marketing authorisations. The BNFC has been designed for rapid reference and the information presented has been carefully selected to aid decisions on prescribing.

      

    Green

    Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications.  

    Amber

    Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate, or initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.

    Some amber medicines require agreement with the local (internal) medicines committee prior to initiation; others may require a framework to support safe transfer and maintenance of care such as a RICaD or ESCA. The Formulary will be annotated to reflect these requirements.   

    Red

    Medicines for initiation and maintenance prescribing by Specialists only  

    Black

    Non-formulary medicines- medicines not recommended for routine primary care prescribing.  

    Grey

    Positive NICE TA and /or awaiting local clarification on place in therapy ; Please contact your Medicines Optimisation team for more information.  

    netFormulary